GOLDMAN SACHS GROUP INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$19,103,977
-29.8%
1,191,021
+1.4%
0.00%
-20.0%
Q2 2023$27,226,301
-15.2%
1,174,560
-15.0%
0.01%
-28.6%
Q1 2023$32,117,960
+59.0%
1,382,607
-0.7%
0.01%
+40.0%
Q4 2022$20,195,250
-34.8%
1,391,816
-14.2%
0.01%
-28.6%
Q3 2022$30,954,000
+30.9%
1,622,321
+24.6%
0.01%
+40.0%
Q2 2022$23,654,000
-40.3%
1,301,781
-17.2%
0.01%
-37.5%
Q1 2022$39,626,000
-22.4%
1,572,441
-15.0%
0.01%
-20.0%
Q4 2021$51,040,000
-25.8%
1,849,261
-13.2%
0.01%
-33.3%
Q3 2021$68,811,000
+1.6%
2,131,040
-3.8%
0.02%0.0%
Q2 2021$67,725,000
+66.4%
2,214,690
+65.7%
0.02%
+50.0%
Q1 2021$40,697,000
+37.3%
1,336,531
-10.8%
0.01%
+25.0%
Q4 2020$29,635,000
+132.3%
1,498,571
+53.2%
0.01%
+100.0%
Q3 2020$12,755,000
-1.5%
978,150
-14.4%
0.00%0.0%
Q2 2020$12,952,000
+61.5%
1,142,151
+103.9%
0.00%
+33.3%
Q1 2020$8,018,000
-44.7%
560,252
+5.2%
0.00%
-25.0%
Q4 2019$14,497,000
-15.1%
532,412
-10.7%
0.00%
-20.0%
Q3 2019$17,072,000
-13.8%
596,307
-16.4%
0.01%
-16.7%
Q2 2019$19,812,000
-22.8%
713,187
-7.7%
0.01%
-25.0%
Q1 2019$25,648,000
+62.3%
772,523
+42.2%
0.01%
+60.0%
Q4 2018$15,798,000
-52.5%
543,455
-24.8%
0.01%
-44.4%
Q3 2018$33,253,000
-16.9%
722,892
-32.5%
0.01%
-18.2%
Q2 2018$40,017,000
-14.2%
1,070,842
-32.2%
0.01%
-8.3%
Q1 2018$46,656,000
+60.3%
1,578,903
+86.4%
0.01%
+71.4%
Q4 2017$29,097,000
-12.1%
847,226
-7.4%
0.01%
-12.5%
Q3 2017$33,113,000
+18.3%
915,216
-15.5%
0.01%
+14.3%
Q2 2017$27,979,000
+46.0%
1,082,744
+8.5%
0.01%
+40.0%
Q1 2017$19,162,000
+25.0%
997,997
+8.5%
0.01%
+25.0%
Q4 2016$15,325,000
-55.1%
919,406
-44.5%
0.00%
-60.0%
Q3 2016$34,100,000
-29.0%
1,656,918
+5.5%
0.01%
-37.5%
Q2 2016$48,052,000
+327.0%
1,570,326
+422.3%
0.02%
+300.0%
Q1 2016$11,254,000
+19.2%
300,658
+37.5%
0.00%0.0%
Q4 2015$9,438,000
-24.7%
218,687
-34.6%
0.00%0.0%
Q3 2015$12,532,000
+50.9%
334,349
+36.8%
0.00%
+33.3%
Q2 2015$8,304,000
-45.7%
244,352
-43.4%
0.00%
-40.0%
Q1 2015$15,289,000
-31.6%
431,881
-34.2%
0.01%
-28.6%
Q4 2014$22,357,000
+36.3%
656,410
+54.4%
0.01%
+40.0%
Q3 2014$16,397,000
-23.3%
425,142
-22.6%
0.01%
-28.6%
Q2 2014$21,369,000
-13.9%
549,033
-24.3%
0.01%
-12.5%
Q1 2014$24,805,000
-59.3%
725,521
-75.0%
0.01%
-60.0%
Q4 2013$60,966,000
+35.6%
2,905,858
+51.9%
0.02%
+25.0%
Q3 2013$44,952,000
-15.5%
1,912,862
-3.4%
0.02%
-23.8%
Q2 2013$53,215,000
+273.4%
1,980,485
+278.7%
0.02%
+320.0%
Q4 2012$14,250,000
+45.4%
522,936
+43.8%
0.01%
+25.0%
Q3 2012$9,799,000
+209.4%
363,580
+172.8%
0.00%
+300.0%
Q2 2012$3,167,000
-35.7%
133,267
-36.0%
0.00%
-50.0%
Q1 2012$4,929,000208,3210.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders